Barbara de Barros

Dec 9, 2024 | journals.plos.org | Priyanka Sivakumaran |Barbara de Barros |Tropical Diseases |Universidade Federal Fluminense

DiscussionWe report good clinical outcome in a cohort of 29 individuals who received mROM for leprosy and were followed for a median period of 3.1 years. The proportion of individuals who experienced a leprosy reaction was 58.6% which is consistent with leprosy reaction rates of approximately 65% at three years in a large Brazilian cohort of individuals with MB leprosy treated with WHO MDT containing rifampicin, clofazimine and dapsone for six or 12 months [5].